Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
for
Immunoglobulin A Nephropathy
Location: Boston MA
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06952426
Recruiting
New
Continuous Wireless Ultrasound to Monitor Fetal Health
for
Pregnant Woman With Single Pregnancy, Ultrasound Fetal Medicine
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: Female
Age: 18+
Code: NCT07676474
Recruiting
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: Boston MA, Lebanon NH, Manhasset NY, New York NY,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05753748
Recruiting
New
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Boston MA, New Hyde Park NY, New York NY,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07890610
Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
for
Asthma
Location: Boston MA, The Bronx NY, Southfield MI,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07301255
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Boston MA, Providence RI, New York NY, Burlington VT,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase 3, Recruiting
Remote Fetal Monitoring in High Risk Pregnancies
for
High Risk Pregnancy, Remote Patient Monitoring, Diabetes,
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: Female
Age: 18+
Code: NCT06822439
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
for
Sarcoid, Cardiovascular Diseases, Cancer
Location: Boston MA
Sponsor: Ralph Weissleder, MD
Sex: All
Age: 18 - 70+
Code: NCT04843891
Phase 1, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Boston MA, Bronx NY, New York NY, Hackensack NJ,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Effectiveness of a Walking Intervention on Impact Loading and Pain
for
Osteoarthritis, Knee, Knee Pain Chronic
Location: Boston MA
Sponsor: Northeastern University
Sex: All
Age: 45+
Code: NCT04148807
Recruiting
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
Location: Boston MA, Hartford CT, New Haven CT, Port Jefferson NY,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Boston MA, Concord NH, Albany NY, New York NY,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,